Johnson & Johnson completed the acquisition of the remaining stake in Verb Surgical from Verily.

Johnson & Johnson, a developer of medical devices, pharmaceutical and consumer packaged goods, completed the acquisition of the remaining stake in Verb Surgical, a manufacturer of robotic medical devices, from Verily, an Alphabet company. Financial terms were not disclosed. The transaction is expected to close in the first half of 2020, subject to antitrust clearance and customary closing conditions. "With Verb Surgical, we set out with an ambitious mission to successfully harmonize the talent and expertise of two pioneers to design a platform with the potential to transform surgery. This evolution in the collaboration recognizes the significant achievement toward that mission and I'm excited for the future of this technology in Johnson & Johnson's hands," Andrew Conrad, Verily CEO.